Menu
Currency
GWAS Study

Mapping of 79 loci for 83 plasma protein biomarkers in cardiovascular disease.

Folkersen L, Fauman E, Sabater-Lleal M et al.

28369058 PubMed ID
GWAS Study Type
6033 Participants
35 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

FL
Folkersen L
FE
Fauman E
SM
Sabater-Lleal M
SR
Strawbridge RJ
FM
Frånberg M
SB
Sennblad B
BD
Baldassarre D
VF
Veglia F
HS
Humphries SE
RR
Rauramaa R
DF
de Faire U
SA
Smit AJ
GP
Giral P
KS
Kurl S
ME
Mannarino E
ES
Enroth S
Johansson Å
ES
Enroth SB
GS
Gustafsson S
LL
Lind L
LC
Lindgren C
MA
Morris AP
GV
Giedraitis V
SA
Silveira A
FA
Franco-Cereceda A
TE
Tremoli E
GU
Gyllensten U
IE
Ingelsson E
BS
Brunak S
EP
Eriksson P
ZD
Ziemek D
HA
Hamsten A
MA
Mälarstig A
Chapter II

Abstract

Summary of the research findings

Recent advances in highly multiplexed immunoassays have allowed systematic large-scale measurement of hundreds of plasma proteins in large cohort studies. In combination with genotyping, such studies offer the prospect to 1) identify mechanisms involved with regulation of protein expression in plasma, and 2) determine whether the plasma proteins are likely to be causally implicated in disease. We report here the results of genome-wide association (GWA) studies of 83 proteins considered relevant to cardiovascular disease (CVD), measured in 3,394 individuals with multiple CVD risk factors. We identified 79 genome-wide significant (p<5e-8) association signals, 55 of which replicated at P<0.0007 in separate validation studies (n = 2,639 individuals). Using automated text mining, manual curation, and network-based methods incorporating information on expression quantitative trait loci (eQTL), we propose plausible causal mechanisms for 25 trans-acting loci, including a potential post-translational regulation of stem cell factor by matrix metalloproteinase 9 and receptor-ligand pairs such as RANK-RANK ligand. Using public GWA study data, we further evaluate all 79 loci for their causal effect on coronary artery disease, and highlight several potentially causal associations. Overall, a majority of the plasma proteins studied showed evidence of regulation at the genetic level. Our results enable future studies of the causal architecture of human disease, which in turn should aid discovery of new drug targets.

3,394 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

6033
Total Participants
GWAS
Study Type
Yes
Replicated
2,639 individuals
Replication Participants
European
Ancestry
Finland, France, Italy, Netherlands, Sweden
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.